A case of iatrogenic severe mitral regurgitation

Submitted: November 25, 2015
Accepted: November 25, 2015
Published: November 25, 2015
Abstract Views: 1167
PDF: 532
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Bromocriptine and cabergoline, ergot derived dopamine receptor agonists used to treat Parkinson’s disease and prolactinomas, have been associated with increased risk of cardiac valve disease. Here we present a case of iatrogenic symptomatic severe mitral regurgitation due to these drugs.



PlumX Metrics


Download data is not yet available.


How to Cite

D’Aloia, Antonio, Barbara Piovanelli, Riccardo Rovetta, Ivano Bonadei, Enrico Vizzardi, Antonio Curnis, and Marco Metra. 2015. “A Case of Iatrogenic Severe Mitral Regurgitation”. Monaldi Archives for Chest Disease 80 (3). https://doi.org/10.4081/monaldi.2013.75.